Skip to main content
  • rainbow over text: 'thank you NHS'
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Almirall SA (ALM) EUR0.12

Sell:€11.90 Buy:€11.93 Change: €0.02 (0.17%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: €0.02 (0.17%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: €0.02 (0.17%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.

Contact details

Ronda General Mitre, 151
+34 (932) 913000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
€2.03 billion
Shares in issue:
173.85 million
Madrid Stock Exchange
Madrid General Index

Key personnel

  • Jorge Gallardo Ballart
    Chairman of the Board
  • Peter Guenter
    Chief Executive Officer, Executive Director
  • Daniel Bravo Andreu
    Second Vice Chairman of the Board
  • David Nieto
    Chief Financial Officer, Executive Vice President - Finance
  • Bhushan Hardas
    Chief Scientific Officer Executive Vice President Research and Development
  • Alfredo Baron de Juan
    Executive Vice President - Global Commercial Operations
  • Amita Kent
    Senior Vice President, Legal and Global Data Protection Officer
  • Esteve Conesa
    Vice President of Human Resources
  • Eloi Crespo Cervera
    Vice President - Manufacturing & Technical Services
  • Joan Figueras Carreras
    Corporate Director, General Counsel

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.